All Locations

Top Companies in Netherlands

418 companies based in Netherlands, sorted by total funding raised.

Tele AtlasAcquired

Digital maps for navigation products and enterprise and consumer solutions

s-Hertogenbosch, Netherlands1001–5000Developer Tools
Private Equity·$210.0M·Apr 2004
QuantWare

Industrial quantum processor company building scalable superconducting quantum chips.

Delft, Netherlands51–200Hardware, Quantum Computing
Series B·$204.0M·May 2026
LL
Leyden Laboratories

Developer of a pan-influenza nasal spray.

Leiden, Netherlands11–50Biotech, Healthcare
Venture Round·$200.0M·Oct 2025
NewAmsterdam

Clinical-stage biotechnology company developing transformative therapies for cardio-metabolic dis...

Amsterdam, NetherlandsSaaS
Series A·$196.0M·Jan 2021
NP
NewAmsterdam PharmaIPO

Clinical-stage biopharmaceutical company advancing novel treatments for cardiovascular disease an...

Naarden, Netherlands51–200Biotech, Healthcare
Series A·$196.0M·Jan 2021
Sendcloud

E-commerce shipping software platform enabling online retailers to integrate multiple carriers, a...

Eindhoven, Netherlands201–500E-Commerce
Series C·$193.1M·Sep 2021
VectorY

VectorY is on a mission to provide patients with neurodegenerative diseases a longer, better life...

Amsterdam, Netherlands51–200Life Sciences
Series A·$175.6M·Nov 2023
VanMoof

VanMoof makes award-winning smart electric bikes designed for urban commuting with integrated ant...

Amsterdam, Netherlands201–500E-Commerce
Series C·$174.5M·Aug 2021
XELTIS

Next-generation heart bypass grafts to naturally restore cardiovascular function.

Eindhoven, Netherlands51–200Biotech, Healthcare
Series D·$159.0M·Feb 2023
MerusAcquired

Clinical-stage biopharmaceutical company developing targeted multispecific antibody treatments fo...

Utrecht, Netherlands201–500Biotech, Healthcare
Series C·$156.0M·Aug 2015
Otrium

Online off-price fashion marketplace connecting brands' end-of-season inventory with consumers to...

Amsterdam, Netherlands51–200E-Commerce, Marketplace
Venture Round·$154.0M·Dec 2023
Framer

No-code website design and publishing platform that empowers users to create, publish, and manage...

Amsterdam, Netherlands51–200Design Tools, Developer Tools
Venture Round·$151.0M·Aug 2025
Neogene TherapeuticsAcquired

Clinical-stage biotech pioneering individualized T-cell receptor (TCR-T) therapies targeting neoa...

Amsterdam, Netherlands51–200Biotech, Healthcare
Series A·$125.0M·Sep 2020
Moove Africa

Mobility fintech company providing vehicle financing to ride-hailing and gig economy drivers acro...

Amsterdam, Netherlands201–500Fintech
Series B·$123.0M·Mar 2024
WeTravel

Operating system for multi-day travel businesses; provides itinerary building, bookings, payments...

Amsterdam, Netherlands201–500Travel & Hospitality
Series C·$123.0M·Sep 2025
Lightyear

Lightyear is a Dutch solar electric vehicle company developing solar charging systems and body pa...

NetherlandsClimate Tech
Venture Round·$120.0M·Jan 2023
Avantium

Renewable chemistry technology for plant-based plastics

Amsterdam, Netherlands201–500Climate Tech
Corporate Round·$118.7M·Sep 2025
Prilenia Therapeutics

Clinical-stage biotech developing novel therapeutics to slow progression of neurodegenerative dis...

Amsterdam, Netherlands11–50Biotech
Series B·$115.5M·Jan 2022
Finom

Finom offers digital financial services for freelancers and small businesses.

Amsterdam, Netherlands501–1000Banking, Financial Services
Growth Equity·$104.5M·Apr 2025
VarmX

The first effective and safe reversal agent to stop or prevent life-threatening bleeding in patie...

Leiden, Netherlands11–50Biotech, Healthcare
Grant·$100.7M·Feb 2025
DataSnipper

DataSnipper is an intelligent automation platform built for audit and finance teams, streamlining...

Amsterdam, Netherlands201–500Financial Services, Fintech
Series B·$100.0M·Jun 2024
MessageBird

Cloud communications platform for omnichannel customer engagement

Amsterdam, Netherlands501–1000SaaS, Cloud Communications
Series C·$100.0M·Apr 2021
BUXAcquired

BUX is a European neobroker app offering commission-free investing in fractional shares, ETFs, an...

Amsterdam, Netherlands51–200Financial Services, Fintech
Series C·$99.4M·Apr 2021
C
CrucellAcquired

Novel vaccine platform

Leiden, Netherlands201–500Biotechnology, pharmaceuticals
Venture Round·$97.0M·Jan 2001
LUMICKS

Next-generation life science tools company enabling immuno-oncology research and drug development...

Amsterdam, NetherlandsBiotech, Healthcare
Series D·$93.0M·Apr 2021